期刊文献+

血清骨源性碱性磷酸酶在维生素D缺乏性佝偻病早期诊断的研究

Early diagnosis for vitamin D deprivation rickets by serum bone alkaline phosphatase
下载PDF
导出
摘要 目的:研究骨源性碱性磷酸酶(BALP)在儿童堆生素D缺乏性佝偻病早期诊断的意义。方法:采用骨源性碱性磷酸酶试荆盒对133例佝偻稿忠病蛆和随机抽取148例正常对照组进行外周血中的BALP、钙、磷、ALP的舍量进行分析。结果:佝偻病患病组外周血BALP的舍量(265.00±29.81)U/L明显高于正常对照组(240.47±22.72)U/L(P〈0.05);枸偻病患病组外周血钙的含量(2.24±0.15)U/L与正常对照组外周血钙的含量(2.33±0.17)U/L比较元显著性差异(P〉0.05)。结论;外周血BALP含量在儿童维生素D缺乏性佝偻病中异常升高,捡出率高于外周血钙;外用血BALP的洲定对佝偻病早期诊断特异性强。 Objective To research early diagnosis for vitamin D deprivation rickets in children by the levels of serum bone alkaline phosphatase(BALP) and calcium. Method Adopt Serum BALP and calcium levels in 133 rickets children and 148 normal children as controls determined by BALP Kit. Results The serum BALP levels were(265.00±29.81)U/L in rickets children,and there was significant difference compared with controls group(240.47±22.72) U/L(P〈0.05). The serum calcium levels were (2.24± 0. 15)U/L in rickets children, and there was not significant difference compared with controls group (2.33±0. 17)U/L(P〉0.05). Conclusion Serum BALP levels were higher in vitamin D deprivation rickets childern. And there is serum BALP high specificity in serum BALP on early diagnosis for vitamin D deprivation rickets.
出处 《医学信息(下旬刊)》 2011年第7期66-67,共2页 Medical information
关键词 骨源性碱性磷酸酶 佝偻病 诊断 bone alkaline phosphatase rickets diagnosi
  • 相关文献

参考文献5

二级参考文献32

  • 1中华人民共和国卫生部.婴幼儿佝偻病防治方案[J].中华儿科杂志,1986,24(6):367-367.
  • 2马贤才 王耀红 等.骨碱性磷酸酶在对佝偻病的诊断实验研究.骨碱性磷酸酶临床应用学术论文集[M].,1998.45.
  • 3首都儿科研究所营养研究室.小儿佝偻病简易诊断与骨碱性磷酸酶结果的初步分析.小儿佝偻病诊断用骨碱性磷酸酶试剂盒技术资料选编[M].北京,-.17.
  • 4俞淑敏 洪庆 等.骨碱性磷酸酶测定在婴幼儿佝偻病诊断中的实用意义[J].现代儿科杂志,1996,1:91-91.
  • 5[1]NIH Consensus Development Panel on Osteoporosis Prevention. Diagnosis and Therapy. JAMA 2001,285:785-795.
  • 6[2]Weinstein RS. True strength. J Bone Miner Res 2000,15:621-625.
  • 7[3]Chesnut Ⅲ CH, Rosen CJ for the Bone Quality Discussion Group. Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res 2001,16:2163-2172.
  • 8[4]Marcus R, Wong M, Heath Ⅲ H, et al. Antiresorptive treatment of posrmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocrine Rev 2002,23:16-37.
  • 9[5]Orimo H, Hayashi Y, Fukunaga M, et al. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 2001,19:331-337.
  • 10[6]Cummings SR, Karpf DB, Harris F, et al. Improvement of spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002,112: 282-289.

共引文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部